Manufacturer

Country

Certificates

Registration Date	16 Nov 2016
Share

LIPODOX

(0)

Medicine Pharmaceuticals Product Number : 47335-082-50

Antineoplastic Agent

Drug Information

NDC Code

47335-082-50

Drug Class

Anthracycline Topoisomerase Inhibitor

Therapeutic Class

Antineoplastic Agent

Dosage form

Solution

Route of Administration

Intravenous Injection

Therapeutic Area

1.treatment of various cancers like advanced breast cancer, advanced ovarian cancer, progressive multiple myeloma, AIDS related Kaposi’s sarcoma.

Indication

Doxorubicin liposome injection is used to treat ovarian cancer and Kaposi sarcoma (AIDS patients). It is also used together with bortezomib to treat multiple myeloma. Doxorubicin liposome is an antineoplastic agent (cancer medicine). Doxorubicin liposome interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by doxorubicin liposome, other unwanted side effects will also occur. Some of these may be serious and must be reported to your doctor.